Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

Phase 3 Completed 600 enrolled Iroko Pharmaceuticals, LLC

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip

Timeline

Start: 2013-03
Primary completion: 2014-06
Completion: 2014-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Meloxicam	Small molecule	—	—

Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

Summary

Timeline

Drugs

Indications